Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Radiotherapy as sole adjuvant treatment for older patients with low-risk breast cancer.

Walker GA, Kaidar-Person O, Kuten A, Morgan DA.

Breast. 2012 Oct;21(5):629-34. doi: 10.1016/j.breast.2012.06.008. Epub 2012 Jul 2. Review.

PMID:
22763240
2.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
3.

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Erratum in: Lancet Oncol. 2015 Mar;16(3):e105.

PMID:
25637340
4.

[Effective treatment strategy in elderly breast cancer patients].

Boér K.

Orv Hetil. 2005 Jan 2;146(1):15-21. Review. Hungarian.

PMID:
15715368
5.

The role of radiotherapy in patients undergoing mastectomy for carcinoma of the breast.

Fernando IN.

Clin Oncol (R Coll Radiol). 2000;12(3):158-65. Review.

PMID:
10942332
6.

A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial.

Prescott RJ, Kunkler IH, Williams LJ, King CC, Jack W, van der Pol M, Goh TT, Lindley R, Cairns J.

Health Technol Assess. 2007 Aug;11(31):1-149, iii-iv.

7.

Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.

Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M.

J Natl Cancer Inst. 2001 Mar 21;93(6):447-55.

PMID:
11259470
8.

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT.

Lancet. 1999 May 15;353(9165):1641-8.

PMID:
10335782
9.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

10.

[Current status of treatment for early-stage invasive breast cancer].

Kásler M, Polgár C, Fodor J.

Orv Hetil. 2009 May 31;150(22):1013-21. doi: 10.1556/OH.2009.28615. Hungarian.

PMID:
19465349
13.

Treatment of breast cancer in countries with limited resources.

Carlson RW, Anderson BO, Chopra R, Eniu AE, Jakesz R, Love RR, Masetti R, Schwartsmann G; Global Summit Treatment Panel.

Breast J. 2003 May-Jun;9 Suppl 2:S67-74.

PMID:
12713499
14.

Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.

Bijker N, Rutgers EJ, Peterse JL, van Dongen JA, Hart AA, Borger JH, Kroon BB.

Cancer. 1999 Apr 15;85(8):1773-81. Review.

PMID:
10223572
15.

Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.

van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJ; EORTC Breast Cancer Group.

Eur J Cancer. 2003 Oct;39(15):2192-9.

PMID:
14522378
16.

Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients.

Koc M, Polat P, Suma S.

Radiother Oncol. 2002 Aug;64(2):171-5.

PMID:
12242127
17.
18.
19.

When may adjuvant radiotherapy be avoided in operable breast cancer?

Kunkler IH, Prescott RJ, Williams LJ, King CC.

Clin Oncol (R Coll Radiol). 2006 Apr;18(3):191-9. Review.

PMID:
16605050
20.

Adjuvant treatment of breast cancer with exemestane.

Kunkler IH.

N Engl J Med. 2004 Jul 1;351(1):100-2; author reply 100-2. No abstract available.

Supplemental Content

Support Center